JTC Team to Host Virtual Investor Niemann-Pick Disease Type C Spotlight Event Featuring Cyclo Therapeutics

- Live video webcast with moderated fireside chat with members of the Cyclo Therapeutics leadership team and Global Principal Investigator for the Phase 3 study, Professor Caroline Hastings, MD, on Monday, May 16th at 2:00 PM ET -FRENCHTOWN, NJ / …